Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
My 2 Favorite Mispriced Dividends For Recurring Income
08:35am, Thursday, 09'th Apr 2026
Rexford Industrial Realty and Pfizer are both priced as if their best days are over, but I see long-term value. REXR benefits from supply-constrained Southern California markets, resilient rent growth
How Pfizer's Oncology Portfolio Is Shaping Up Before Q1 Results
12:20pm, Wednesday, 08'th Apr 2026
Pfizer PFE is one of the largest and most successful drugmakers in oncology with an established presence in breast, genitourinary, thoracic, gastrointestinal cancer and blood cancers. It boasts a str
Asio Capital LLC Takes $2.86 Million Position in Pfizer Inc. $PFE
03:31am, Wednesday, 08'th Apr 2026
Asio Capital LLC purchased a new stake in shares of Pfizer Inc. (NYSE: PFE) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. T
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
06:46pm, Tuesday, 07'th Apr 2026
Pfizer (PFE) concluded the recent trading session at $27.1, signifying a -2.62% move from its prior day's close.
Why Pfizer Stock Tumbled on Tuesday
04:11pm, Tuesday, 07'th Apr 2026
He continues to consider Pfizer a sell. The pundit's main concern is the company's weaknesses in three key products.
Why Is Pfizer Stock Dropping Tuesday?
01:54pm, Tuesday, 07'th Apr 2026
Pfizer sentiment is also getting tugged by Washington policy risk after a potential 100% tariffs framework surfaced for drugmakers without pricing deals, with an announcement timeline as soon as Thurs
Prediction: In 5 Years, You'll Wish You Bought Pfizer Stock Today
10:00am, Tuesday, 07'th Apr 2026
Pfizer's declining revenue and questions about its growth have weighed down the stock in recent years. The company, however, has been bolstering its pipeline and has some exciting assets.
High Yield vs. Sustainable Growth: Why AbbVie's Dividend Beats Pfizer's Despite the Lower Payout
12:15pm, Monday, 06'th Apr 2026
Pharmaceutical companies AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, revealing two very different pharmaceutical stories.
Leo Wealth LLC Acquires 27,559 Shares of Pfizer Inc. $PFE
07:15am, Monday, 06'th Apr 2026
Leo Wealth LLC grew its holdings in shares of Pfizer Inc. (NYSE: PFE) by 25.4% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned
Pfizer Inc. $PFE Shares Sold by Stratos Wealth Partners LTD.
05:35am, Monday, 06'th Apr 2026
Stratos Wealth Partners LTD. reduced its holdings in shares of Pfizer Inc. (NYSE: PFE) by 14.3% in the undefined quarter, according to the company in its most recent disclosure with the Securities and
Capricorn Fund Managers Ltd Invests $4.12 Million in Pfizer Inc. $PFE
04:43am, Monday, 06'th Apr 2026
Capricorn Fund Managers Ltd bought a new stake in Pfizer Inc. (NYSE: PFE) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Com
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (April 2026)
08:10am, Saturday, 04'th Apr 2026
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
Aberdeen Group plc Sells 664,801 Shares of Pfizer Inc. $PFE
03:09am, Friday, 03'rd Apr 2026
Aberdeen Group plc lessened its position in Pfizer Inc. (NYSE: PFE) by 11.3% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,205
Trump Administration Unveils Up to 100% Tariff on Branded Drugs
05:34pm, Thursday, 02'nd Apr 2026
Drugmakers or countries that strike pricing deals or make manufacturing investment commitments in the U.S. can secure much lower levies, or none at all.
3 Monster Dividend Stocks to Hold for the Next 10 Years
05:15am, Thursday, 02'nd Apr 2026
Philip Morris has a strong position in the nicotine market, which should help its dividend grow. Investors are too pessimistic about Pfizer's future, even as it pays a huge dividend yield right now.
